names of glp 1 agonists list medications GLP-1/GIP Receptor and Diabetic Retinopathy: What ODs Should Ever wondered what the buzz

The surge in unregulated GLP-1 use is driven by cost, supply issues and social media hype, according to Dumont

Rowbottom, L., Stinson, J., McDonald, R., Emmenegger, U., Cheng, S., Lowe, J., Giotis, A., Cheon, P., Chow, R., Pasetka, M., et al

Histological evidence of nephropathy was attenuated using dapagliflozin (another SGLT2 inhibitor), which reduces gene expression of inflammation and oxidative stress in the kidney of db/db mice

Safety vigilance, thoughtful patient selection, and integration with behavioural care are the practical requirements for translating trial efficacy into real-world benefit

44 Knee osteoarthritis GLP-1 RAs may also have therapeutic potential in knee osteoarthritis, a condition in which excess weight exacerbates joint degeneration, inflammation, and pain

Beyond potential direct neuroprotective effects, these medications address several modifiable risk factors for dementia